Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Work In Process (2020 - 2023)

Trulieve Cannabis has reported Work In Process over the past 4 years, most recently at $134.2 million for Q2 2023.

  • For Q2 2023, Work In Process rose 9.37% year-over-year to $134.2 million; the TTM value through Jun 2023 reached $134.2 million, up 9.37%, while the annual FY2022 figure was $158.4 million, 68.12% up from the prior year.
  • Work In Process for Q2 2023 was $134.2 million at Trulieve Cannabis, down from $165.9 million in the prior quarter.
  • Over five years, Work In Process peaked at $165.9 million in Q1 2023 and troughed at $51.5 million in Q1 2021.
  • A 4-year average of $106.1 million and a median of $99.7 million in 2022 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: soared 158.24% in 2022 and later rose 9.37% in 2023.
  • Year by year, Work In Process stood at $54.8 million in 2020, then surged by 72.05% to $94.2 million in 2021, then soared by 68.12% to $158.4 million in 2022, then fell by 15.32% to $134.2 million in 2023.
  • Business Quant data shows Work In Process for TCNNF at $134.2 million in Q2 2023, $165.9 million in Q1 2023, and $158.4 million in Q4 2022.